Kiki Schraa

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

Viola Klück, Tim Jansen, M. Janssen et al. · The Lancet Rheumatology · 2020 · 257 citations · Full text

Anti-inflammatory, Gouty Arthritis, Pharmacology +8

Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk

Alexander Kurilshikov, Inge C.L. van den Munckhof, Lianmin Chen et al. · Circulation Research · 2019 · 186 citations · Full text

Sex-Specific Regulation of Inflammation and Metabolic Syndrome in Obesity

Rob ter Horst, Inge van den Munckhof, Kiki Schraa et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2020 · 132 citations · Full text

Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males

Maartje C. P. Cleophas, Jacqueline M. Ratter, Siroon Bekkering et al. · Scientific Reports · 2019 · 131 citations · Full text

Genetic and Microbial Associations to Plasma and Fecal Bile Acids in Obesity Relate to Plasma Lipids and Liver Fat Content

Lianmin Chen, Inge van den Munckhof, Kiki Schraa et al. · Cell Reports · 2020 · 91 citations · Full text